MetLife Investment Management’s Exponent EXPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.01M | Buy |
51,301
+511
| +1% | +$31.4K | 0.01% | 909 |
|
|
2026
Q1 | $3.31M | Sell |
50,790
-1,091
| -2% | -$77.5K | 0.02% | 804 |
|
|
2025
Q4 | $3.6M | Sell |
51,881
-2,825
| -5% | -$198K | 0.02% | 782 |
|
|
2025
Q3 | $3.8M | Sell |
54,706
-2,074
| -4% | -$148K | 0.02% | 759 |
|
|
2025
Q2 | $4.24M | Buy |
56,780
+222
| +0.4% | +$17.2K | 0.02% | 649 |
|
|
2025
Q1 | $4.58M | Sell |
56,558
-1,773
| -3% | -$154K | 0.02% | 654 |
|
|
2024
Q4 | $5.2M | Buy |
58,331
+4,461
| +8% | +$449K | 0.03% | 537 |
|
|
2024
Q3 | $6.21M | Sell |
53,870
-1,063
| -2% | -$111K | 0.04% | 424 |
|
|
2024
Q2 | $5.23M | Buy |
54,933
+2,217
| +4% | +$200K | 0.03% | 462 |
|
|
2024
Q1 | $4.36M | Sell |
52,716
-1,265
| -2% | -$105K | 0.03% | 568 |
|
|
2023
Q4 | $4.75M | Sell |
53,981
-574
| -1% | -$47K | 0.03% | 483 |
|
|
2023
Q3 | $4.67M | Sell |
54,555
-1,754
| -3% | -$159K | 0.04% | 448 |
|
|
2023
Q2 | $5.25M | Sell |
56,309
-309
| -0.5% | -$29.1K | 0.04% | 410 |
|
|
2023
Q1 | $5.64M | Buy |
56,618
+30,003
| +113% | +$3.05M | 0.04% | 383 |
|
|
2022
Q4 | $2.64M | Sell |
26,615
-783
| -3% | -$76.1K | 0.02% | 781 |
|
|
2022
Q3 | $2.4M | Buy |
27,398
+661
| +2% | +$62.7K | 0.02% | 801 |
|
|
2022
Q2 | $2.45M | Sell |
26,737
-1,111
| -4% | -$105K | 0.02% | 820 |
|
|
2022
Q1 | $3.01M | Buy |
27,848
+9,879
| +55% | +$953K | 0.02% | 813 |
|
|
2021
Q4 | $2.1M | Hold |
17,969
| – | – | 0.02% | 851 |
|
|
2021
Q3 | $2.03M | Sell |
17,969
-793
| -4% | -$85.5K | 0.02% | 849 |
|
|
2021
Q2 | $1.67M | Hold |
18,762
| – | – | 0.01% | 941 |
|
|
2021
Q1 | $1.83M | Sell |
18,762
-1,222
| -6% | -$115K | 0.02% | 903 |
|
|
2020
Q4 | $1.8M | Sell |
19,984
-1,255
| -6% | -$100K | 0.02% | 882 |
|
|
2020
Q3 | $1.53M | Sell |
21,239
-1,176
| -5% | -$93.5K | 0.02% | 836 |
|
|
2020
Q2 | $1.81M | Buy |
22,415
+829
| +4% | +$59.7K | 0.02% | 757 |
|
|
2020
Q1 | $1.55M | Hold |
21,586
| – | – | 0.02% | 706 |
|
|
2019
Q4 | $1.49M | Sell |
21,586
-1,406
| -6% | -$92.8K | 0.02% | 926 |
|
|
2019
Q3 | $1.61M | Hold |
22,992
| – | – | 0.02% | 865 |
|
|
2019
Q2 | $1.35M | Sell |
22,992
-42,564
| -65% | -$2.42M | 0.01% | 978 |
|
|
2019
Q1 | $3.78M | Buy |
65,556
+43,704
| +200% | +$2.36M | 0.01% | 963 |
|
|
2018
Q4 | $1.11M | Sell |
21,852
-1,732
| -7% | -$86.9K | 0.01% | 981 |
|
|
2018
Q3 | $1.26M | Hold |
23,584
| – | – | 0.01% | 1029 |
|
|
2018
Q2 | $1.14M | Buy |
23,584
+1,430
| +6% | +$65.6K | 0.01% | 971 |
|
|
2018
Q1 | $871K | Sell |
22,154
-2,642
| -11% | -$99.9K | 0.01% | 1063 |
|
|
2017
Q4 | $881K | Buy |
+24,796
| New | +$910K | 0.01% | 1080 |
|
Other funds holding EXPO
MetLife Investment Management's EXPO Position: Q2 2026 in Review
MetLife Investment Management increased its Exponent (EXPO) stake by 1% in Q2 2026, buying an estimated $31.4K and bringing the position to 51,301 shares worth $3.01M. The position accounts for 0.01% of the portfolio, ranked #909.
MetLife Investment Management first reported a position in EXPO in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.21M in Q3 2024. 340 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.
- MetLife Investment Management held 51,301 shares of Exponent worth $3.01M as of Q2 2026.
- MetLife Investment Management bought 511 Exponent shares in Q2 2026, an estimated $31.4K.
- Exponent made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #909 holding.
- MetLife Investment Management first reported a position in Exponent in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Exponent position peaked at $6.21M in Q3 2024.
- 340 funds tracked by Wall St. Rank held Exponent as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.